Utilities Healthcare Sector

Aardvark Therapeutics

Market Cap: US$227.8m

A clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases.

Optima Health

Market Cap: UK£168.7m

Provides occupational health and wellbeing services for the public and private sectors in the United Kingdom.

Dimerix

Market Cap: AU$354.4m

A biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs in Australia.

Jade Biosciences

Market Cap: US$226.6m

Operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases.

Astria Therapeutics

Market Cap: US$221.2m

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for allergic and immunological diseases in the United States.

MediWound

Market Cap: US$220.2m

A biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States and internationally.

Tactile Systems Technology

Market Cap: US$219.0m

A medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States.

Solid Biosciences

Market Cap: US$217.8m

Develops therapies for neuromuscular and cardiac diseases in the United States.

Fennec Pharmaceuticals

Market Cap: US$217.4m

Operates as a commercial stage biopharmaceutical company in the United States.

Medical Facilities

Market Cap: CA$300.3m

Through its subsidiaries, owns and operates specialty surgical hospitals and ambulatory surgery center in the United States.

Monopar Therapeutics

Market Cap: US$216.7m

A clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States.

Design Therapeutics

Market Cap: US$216.3m

A clinical-stage biopharmaceutical company, research, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States.

enGene Holdings

Market Cap: US$216.1m

Through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company that develops genetic medicines to help patients suffering from bladder cancer.

OptimizeRx

Market Cap: US$215.5m

Operates as a digital healthcare technology company.

Performant Healthcare

Market Cap: US$214.6m

Provides audit, recovery, and analytics services in the United States.

Bioventix

Market Cap: UK£155.2m

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide.

ProKidney

Market Cap: US$208.0m

A clinical-stage biotechnology company, develops a cell therapy platform for the treatment of multiple chronic kidney diseases in the United States.

VitaSpring Biomedical

Market Cap: US$207.0m

Focuses on the development of drugs of cell medicine.

Bright Minds Biosciences

Market Cap: CA$281.8m

A biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States.

Integrated Diagnostics Holdings

Market Cap: US$203.5m

Operates as a consumer healthcare company that provides medical diagnostics services to patients.

Actuate Therapeutics

Market Cap: US$202.7m

A clinical-stage biopharmaceutical company, develops therapies for the treatment of cancers in the United States.

Cardiff Oncology

Market Cap: US$201.6m

A clinical-stage biotechnology company, develops novel therapies for the treatment of various cancers.

BioStem Technologies

Market Cap: US$200.0m

A life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services.

Tango Therapeutics

Market Cap: US$199.4m

A precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need.

Codexis

Market Cap: US$198.8m

Provides enzymatic solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, and enhance novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China.

Y-mAbs Therapeutics

Market Cap: US$195.6m

A commercial-stage biopharmaceutical company, focuses on the development and commercialization of radioimmunotherapy and antibody based therapeutic products for the treatment of cancer.

Orthocell

Market Cap: AU$302.5m

A regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia, the United States, the United Kingdom, and the European Union.

UroGen Pharma

Market Cap: US$193.2m

Engages in the development and commercialization of solutions for urothelial and specialty cancers.

4basebio

Market Cap: UK£142.1m

Engages in the research, development, manufacturing, and commercialization of synthetic DNA and RNA products, and targeted non-viral vector solutions in the United States, Europe, and internationally.

Monash IVF Group

Market Cap: AU$298.1m

Provides assisted reproductive and specialist women imaging services in Australia and Malaysia.

SOPHiA GENETICS

Market Cap: US$190.4m

Operates as a cloud-native software technology company in the healthcare space.

ME Therapeutics Holdings

Market Cap: CA$261.9m

A preclinical stage biotechnology company, engages in the development of cancer fighting drugs in the field of immuno-oncology.

CARGO Therapeutics

Market Cap: US$189.1m

A clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients.

OraSure Technologies

Market Cap: US$188.5m

Develops, manufactures, markets, sells, and distributes diagnostic products, specimen collection devices, and other diagnostic products in the United States, Europe, Africa, and internationally.

Quanterix

Market Cap: US$188.3m

A life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions.

Pacific Smiles Group

Market Cap: AU$292.5m

Owns and operates dental centers under the Pacific Smiles Dental Centres and Nib Dental Care Centres names in Australia.